Chartwell Pharmaceuticals
Nirav Patel is a skilled Technical Services Manager currently employed at Chartwell Pharmaceuticals since April 2022, with a robust background in technical services spanning over a decade. Previously, Nirav Patel held various positions at Lannett Company from July 2015 to April 2022, including Technical Services Manager, Technical Services Supervisor, Supervisor R&D, and Group Leader. Prior experience includes a role as Sr Chemist at Silarx Pharmaceuticals Inc from May 2012 to June 2015 and Scientist III at Amneal Pharmaceuticals from December 2008 to May 2012. Nirav Patel is proficient in modern analytical techniques, including HPLC, GC, and several other instrumental methods, and has expertise in the development and validation of analytical methods following cGMP compliance. Educational qualifications include a Master’s in Pharmaceutical Science from LIU Brooklyn and a Bachelor of Pharmacy from Rajiv Gandhi University of Health Sciences.
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.